Public Employees Retirement System Of Ohio Reata Pharmaceuticals Inc Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Dec 19, 2023	BUY	$22.15 - $42.11 $97,770 - $185,873	4,414 New	4,414 $167,000
Q4 2022 Feb 15, 2023	SELL	$22.15 - $42.11 $22,194 - $42,194	-1,002 Reduced 18.5%	4,414 $168,000
Q3 2022 Nov 15, 2022	BUY	$19.41 - $36.49 $105,124 - $197,629	5,416 New	5,416 $136,000
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $1.09 Million - $2.1 Million	-13,888 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $195,851 - $275,979	2,078 Added 17.6%	13,888 $1.39 Million
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $117,946 - $213,420	1,156 Added 10.85%	11,810 $1.46 Million
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $150,957 - $263,630	1,614 Added 17.85%	10,654 $1.04 Million
Q2 2020 Aug 17, 2020	BUY	$126.3 - $176.56 $1.14 Million - $1.6 Million	9,040 New	9,040 $1.41 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account